Nodular regenerative hyperplasia: A deleterious consequence of chemotherapy for colorectal liver metastases?

Liver International

Volumn 27, Issue 7, 2007, Pages 938-943

  Hubert, Catherine ^a   Sempoux, Christine ^a   Horsmans, Yves ^a   Rahier, Jacques ^a   Humblet, Yves ^a   Machiels, Jean Pascal ^a   Ceratti, Antonino ^a   Canon, Jean Luc ^b   Gigot, Jean François ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b Clinique Notre Dame   (Belgium)

Author keywords

Chemotherapy; Liver toxicity; Metastases; Nodular regenerative hyperplasia

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; FLUOROURACIL; FOLINIC ACID; GAMMA GLUTAMYLTRANSFERASE; OXALIPLATIN;

ADJUVANT THERAPY; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ARTIFICIAL EMBOLISM; ASCITES; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CASE REPORT; COLORECTAL CANCER; DISEASE COURSE; ESOPHAGUS VARICES; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HUMAN; LIVER BIOPSY; LIVER FAILURE; LIVER HYPERPLASIA; LIVER METASTASIS; LIVER NODULE; MALE; METASTASIS; MULTIPLE CYCLE TREATMENT; NODULAR HYPERPLASIA; PORTAL HYPERTENSION; SPLENOMEGALY; TREATMENT CONTRAINDICATION;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; FEMALE; FLUOROURACIL; HEPATECTOMY; HUMANS; HYPERPLASIA; LIVER; LIVER DISEASES; LIVER FUNCTION TESTS; LIVER NEOPLASMS; LIVER REGENERATION; MALE; MIDDLE AGED; ORGANOPLATINUM COMPOUNDS; TIME FACTORS; TREATMENT OUTCOME;

EID: 34547908890     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2007.01511.x     Document Type: Article

References (26)

1. Colina F, Alberti N, Solis JA, Martinez-Tello FJ. Diffuse nodular regenerative hyperplasia of the liver (DNRH). A clinicopathologic study of 24 cases. Liver 1989; 9: 253-65.
2. Nakanuma Y. Nodular regenerative hyperplasia of the liver: Retrospective survey in autopsy series. J Clin Gastroenterol 1990; 12: 460-5.
3. Wanless IR. Micronodular transformation (Nodular Regenerative Hyperplasia) of the liver: A report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular carcinoma. Hepatology 1990; 11: 787-97.
4. Wanless IR, Godwin TA, Allen F, Feder A. Nodular regenerative hyperplasia of the liver in hematologic disorders: A possible response to obliterative portal venopathy. A morphometric study of nine cases with an hypothesis on the pathogenesis. Medicine (Baltimore) 1980; 59: 367-79.
5. Shimamatsu K, Wanless IR. Role of ischemia in causing apoptosis, atrophy, and nodular hyperplasia in human liver. Hepatology 1997; 26: 343-50.
6. Roskams T, Baptista A, Bianchi L, et al. Histopathology of portal hypertension: A practical guideline. Histopathology 2003; 42: 2-13.
7. Molina E, Reddy KR. Noncirrhotic portal hypertension. Clin Liver Dis 2001; 5: 769-87.
8. Dachman AH, Ros PR, Goodman ZD, Olmsted WW, Ishak KG. Nodular regenerative hyperplasia of the liver: Clinical and radiologic observations. AJR 1987; 148: 717-22.
9. Stromeyer FW, Ishak KG. Nodular transformation (nodular "regenerative" hyperplasia) of the liver. A clinicopathologic study of 30 cases. Hum Pathol 1981; 12: 60-71.
10. Washington K, Lane KL, Meyers WC. Nodular regenerative hyperplasia in partial hepatectomy specimens. Am J Surg Pathol 1993; 17: 1151-8.
11. Rubbia-Brandt L, Audard V, Sartoretti P, et al. Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol 2004; 15: 460-6.
12. Rubbia-Brandt L, Mentha G, Terris B. Sinusoidal obstruction syndrome is a major feature of hepatic lesions associated with Oxaliplatin neoadjuvant chemotherapy for liver colorectal metastases. J Am Coll Surg 2006; 202: 199-200.
13. DeLeve LD, Shulman HM, McDonald GB. Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease). Semin Liver Dis 2002; 22: 27-42.
14. Trotter JF, Everson GT. Benign focal lesions of the liver. Clin Liver Dis 2001; 5: 17-42, v.
15. Rosen AA, Iseri O, Fishbein G, Knodell RG. Nodular regenerative hyperplasia: A cause of ascitis and hepatomegaly after chemotherapy for leukaemia. Am J Gastroenterol 1991; 86: 86-8.
16. Tisman G, MacDonald D, Shindell N, et al. Oxaliplatin toxicity masquerading as recurrent colon cancer. J Clin Oncol 2004; 22: 3202-4.
17. de Gramont A, Figer A, Seymour M, et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 2000; 18: 2938-47.
18. Tournigand C, Andre T, Achille E, et al. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: A randomized GERCOR study. J Clin Oncol 2004; 22: 229-37.
19. Tournigand C, Cervantes A, Figer A, et al. OPTIMOX1: A randomized study of FOLFOX4 or FOLFOX7 with oxaliplatin in a stop-and-Go fashion in advanced colorectal cancer - a GERCOR study. J Clin Oncol 2006; 24: 394-400.
20. Andre T, Boni C, Mounedji-Boudiaf L, et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 2004; 350: 2343-51.
21. Fernandez FG, Ritter J, Goodwin JW, Linehan DC, Hawkins WG, Strasberg SM. Effect of steatohepatitis associated with Irinotecan or Oxaliplatin pretreatment on resectability of hepatic colorectal metastases. J Am Coll Surg 2005; 200: 845-53.
22. Vauthey JN, Pawlik TM, Ribero D, et al. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 2006; 24: 2065-72.
23. Steiner PE. Nodular regenerative hyperplasia of the liver. Am J Pathol 1959; 35: 943-53.
24. Snover DC, Weisdorf S, Bloomer J, McGlave P, Weisdorf D. Nodular regenerative hyperplasia of the liver following bone marrow transplantation. Hepatology 1989; 9: 443-8.
25. Abdalla EK, Hicks ME, Vauthey JN. Portal vein embolization: Rationale, technique and future prospects. Br J Surg 2001; 88: 165-75.
26. Di Stefano DR, de Baere T, Denys A, et al. Preoperative percutaneous portal vein embolization: Evaluation of adverse events in 188 patients. Radiology 2005; 234: 625-30.